IL6 and breast cancer: Both BaP and PCB exposures can result in perturbation of inflammation mediators, leading to an inflammation microenvironment (via TNF-α and NFκB leading to IL-6 upregulation) that facilitates and contributes to the migration and invasion of breast cancer cells [67, 68].